Non-Invasive Hemodynamic Whole-Body Bioimpedance Indices for the Early Detection of Cancer Treatment-Related Cardiotoxicity: A Retrospective Observational Study

Nili Schamroth Pravda, Shaul Lev , Osnat Itzhaki Ben Zadok, Ran Kornowski, Zaza Iakobishvili

Conclusion: GGI, a parameter measured by WBI, can reliably correlate to biomarker evidence of heart failure in patients after chemotherapy. Its use as a screening tool for cardiotoxicity in patients with ongoing anticancer therapy is promising.

For the full article click here

Contact Us

Skip to content